Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
iRhythm Technologies
(NASDAQ:IRTC)
Intraday
$111.27
-5.16
[-4.43%]
After-Hours
$111.27
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$111.27
-5.16
[-4.43%]
At close: Apr 25
$111.27
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Q1 2024 Earnings in 6 days from now on Thu May 2nd, after the market close
Conference call scheduled in 6 days at 16:30 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for iRhythm Technologies Stock (NASDAQ:IRTC)
iRhythm Technologies Stock (NASDAQ: IRTC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, March 05, 2024
iRhythm Prices Upsized Offering Of $575M Of 1.50% Convertible Senior Notes Due 2029
Benzinga Newsdesk
-
Mar 5, 2024, 1:36AM
Monday, March 04, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Mar 4, 2024, 12:35PM
iRhythm Technologies shares are trading lower after the company announced a $450 million proposed offering of convertible senior notes.
Benzinga Newsdesk
-
Mar 4, 2024, 11:10AM
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Avi Kapoor
-
Mar 4, 2024, 10:40AM
iRhythm Announces Proposed Offering Of $450M Of Convertible Senior Notes
Benzinga Newsdesk
-
Mar 4, 2024, 6:46AM
Thursday, February 29, 2024
iRhythm Collaborates With Epic To Streamline Access To Zio Service And Drive More Seamless Connectivity Between Clinicians And Patients
Benzinga Newsdesk
-
Feb 29, 2024, 4:58PM
Friday, February 23, 2024
iRhythm Technologies shares are trading lower after the company reported mixed Q4 financial results.
Benzinga Newsdesk
-
Feb 23, 2024, 3:47PM
Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $133
Benzinga Newsdesk
-
Feb 23, 2024, 9:48AM
Critical Insights From iRhythm Technologies Analyst Ratings: What You Need To Know
Benzinga Insights
-
Feb 23, 2024, 7:00AM
Needham Maintains Buy on iRhythm Technologies, Raises Price Target to $137
Benzinga Newsdesk
-
Feb 23, 2024, 5:21AM
Thursday, February 22, 2024
Recap: iRhythm Technologies Q4 Earnings
Benzinga Insights
-
Feb 22, 2024, 4:25PM
iRhythm Technologies Sees FY24 Revenue $575M-$585M Vs $581.062M Est.
Benzinga Newsdesk
-
Feb 22, 2024, 4:14PM
iRhythm Technologies Q4 2023 Adj EPS $(0.84) Misses $(0.60) Estimate, Sales $132.50M Beat $130.24M Estimate
Benzinga Newsdesk
-
Feb 22, 2024, 4:09PM
Earnings Scheduled For February 22, 2024
Benzinga Insights
-
Feb 22, 2024, 5:27AM
Monday, January 08, 2024
A Glimpse Into The Expert Outlook On iRhythm Technologies Through 6 Analysts
Benzinga Insights
-
Jan 8, 2024, 2:01PM
Needham Maintains Buy on iRhythm Technologies, Raises Price Target to $136
Benzinga Newsdesk
-
Jan 8, 2024, 1:33PM
iRhythm Technologies shares are trading higher after the company announced a business update and share preliminary Q4 highlights at the J.P. Morgan Healthcare Conference.
Benzinga Newsdesk
-
Jan 8, 2024, 11:48AM
iRhythm Technologies Shares Preliminary Q4 2023 Highlights And Business Update At The 42nd Annual J.P. Morgan Healthcare Conference; Grew Q4 2023 Patient Registrations In Excess Of 22% YoY; Sees FY24 Revenue $575M-$585M Vs 578.72M Est.
Benzinga Newsdesk
-
Jan 8, 2024, 8:41AM
Wednesday, January 03, 2024
iRhythm Technologies Receives European Union's CE Marking Under Medical Device Regulation For Zio Monitor And ZEUS System
Benzinga Newsdesk
-
Jan 3, 2024, 8:28AM
Friday, December 22, 2023
Truist Securities Maintains Buy on iRhythm Technologies, Raises Price Target to $133
Benzinga Newsdesk
-
Dec 22, 2023, 10:17AM
Tuesday, December 12, 2023
Analyst Expectations for iRhythm Technologies's Future
Benzinga Insights
-
Dec 12, 2023, 1:00PM
Truist Securities Maintains Buy on iRhythm Technologies, Raises Price Target to $115
Benzinga Newsdesk
-
Dec 12, 2023, 11:54AM
Monday, December 11, 2023
Citigroup Upgrades iRhythm Technologies to Buy, Announces $110 Price Target
Benzinga Newsdesk
-
Dec 11, 2023, 8:56AM
Friday, November 03, 2023
What 4 Analyst Ratings Have To Say About iRhythm Technologies
Benzinga Insights
-
Nov 3, 2023, 2:00PM
Needham Maintains Buy on iRhythm Technologies, Lowers Price Target to $108
Benzinga Newsdesk
-
Nov 3, 2023, 6:52AM
Thursday, November 02, 2023
iRhythm Technologies Q3 2023 Adj EPS $(0.79) Misses $(0.66) Estimate, Revenue $124.6M Beats $122.56M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 4:17PM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Wednesday, October 25, 2023
Shares of healthcare equipment and tools stocks are trading lower in sympathy with Thermo Fisher and Danaher.
Benzinga Newsdesk
-
Oct 25, 2023, 3:03PM
Wednesday, October 11, 2023
Analyst Ratings for iRhythm Technologies
Benzinga Insights
-
Oct 11, 2023, 2:00PM
Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $135
Benzinga Newsdesk
-
Oct 11, 2023, 10:04AM
Monday, August 28, 2023
Analyst Ratings for iRhythm Technologies
Benzinga Insights
-
Aug 28, 2023, 11:00AM
Canaccord Genuity Maintains Buy on iRhythm Technologies, Lowers Price Target to $116
Benzinga Newsdesk
-
Aug 28, 2023, 9:20AM
Friday, August 11, 2023
Massive Insider Trade At iRhythm Technologies
Benzinga Insights
-
Aug 11, 2023, 11:03AM
Monday, August 07, 2023
IRhythm Technologies' Cost Efficiency And Potential Entry Into The Japanese Market Earn Analyst Applaud
Nabaparna Bhattacharya
-
Aug 7, 2023, 2:32PM
Truist Securities Maintains Buy on iRhythm Technologies, Lowers Price Target to $138
Benzinga Newsdesk
-
Aug 7, 2023, 11:15AM
Friday, August 04, 2023
Strong Zio AT Business Growth Propels iRhythm's Q2 Revenue Surge, Analysts Say Warning Letter Manageable
Vandana Singh
-
Aug 4, 2023, 2:18PM
Morgan Stanley Reiterates Overweight on iRhythm Technologies, Maintains $149 Price Target
Benzinga Newsdesk
-
Aug 4, 2023, 2:11PM
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Aug 4, 2023, 12:55PM
iRhythm Technologies shares are trading higher after the company reported better-than-expected Q2 results.
Benzinga Newsdesk
-
Aug 4, 2023, 11:23AM
Chief Technology Officer at iRhythm Technologies Exercises Options Worth $56K
Benzinga Insights
-
Aug 4, 2023, 11:00AM
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
Lisa Levin
-
Aug 4, 2023, 10:32AM
Needham Maintains Buy on iRhythm Technologies, Lowers Price Target to $130
Benzinga Newsdesk
-
Aug 4, 2023, 6:34AM
Thursday, August 03, 2023
iRhythm Technologies Q2 Adj EPS $(0.43) Beats $(0.78) Estimate, Sales $124.13M Beat $120.34M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 4:44PM
Earnings Scheduled For August 3, 2023
Benzinga Insights
-
Aug 3, 2023, 6:59AM
Wednesday, July 19, 2023
iRhythm Technologies' Market-Leading ZioService to Dominate ACM Sector: Analyst Initiates with Outperform Rating
Vandana Singh
-
Jul 19, 2023, 1:41PM
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Benzinga Insights
-
Jul 19, 2023, 11:00AM
Baird Initiates Coverage On iRhythm Technologies with Outperform Rating, Announces Price Target of $130
Benzinga Newsdesk
-
Jul 19, 2023, 4:52AM
Tuesday, July 11, 2023
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Jul 11, 2023, 1:38PM
What 11 Analyst Ratings Have To Say About iRhythm Technologies
Benzinga Insights
-
Jul 11, 2023, 11:00AM
Morgan Stanley Reiterates Overweight on iRhythm Technologies, Maintains $149 Price Target
Benzinga Newsdesk
-
Jul 11, 2023, 9:22AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch